# A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

> **NCT03994549** · EARLY_PHASE1 · COMPLETED · sponsor: **Zealand Pharma** · enrollment: 64 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dual GLP-1/GLP-2 Receptor agonists

## Key facts

- **NCT ID:** NCT03994549
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-14
- **Primary completion:** 2020-11-02
- **Final completion:** 2020-11-02
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03994549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03994549, "A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03994549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*